Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie Federico

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
Trends in Pharmacological Sciences|November 6, 2015
Advances in Computational Techniques to Study GPCR-Ligand RecognitionAntonella Ciancetta, Davide Sabbadin, Stephanie Federico, et al.
Current Medicinal Chemistry|February 16, 2022
Glycogen Synthase Kinase 3β Involvement in Neuroinflammation and Neurodegenerative DiseasesTeresa Gianferrara, Eleonora Cescon, Ilenia Grieco, et al.
International Journal of Molecular Sciences|May 14, 2022
The Multifaceted Role of GPCRs in Amyotrophic Lateral Sclerosis: A New Therapeutic Perspective?Davide Bassani, Matteo Pavan, Stephanie Federico, et al.
Chemmedchem|October 26, 2018
Targeting Protein Kinase CK1δ with Riluzole: Could It Be One of the Possible Missing Bricks to Interpret Its Effect in the Treatment of ALS from a Molecular Point of View?Maicol Bissaro, Stephanie Federico, Veronica Salmaso, et al.
Drug Discovery Today|May 19, 2019
The current status of pharmacotherapy for the treatment of Parkinson's disease: transition from single-target to multitarget therapySiew L Cheong, Stephanie Federico, Giampiero Spalluto, et al.
RSC Medicinal Chemistry|May 28, 2021
Potent and selective A<sub>3</sub> adenosine receptor antagonists bearing aminoesters as heterobifunctional moietiesStephanie Federico, Enrico Margiotta, Stefano Moro, et al.
Current Topics in Medicinal Chemistry|May 7, 2016
Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines and Structurally Simplified Analogs. Chemistry and SAR Profile as Adenosine Receptor AntagonistsSara Redenti, Antonella Ciancetta, Giorgia Pastorin, et al.
European Journal of Medicinal Chemistry|December 3, 2019
Conjugable A<sub>3</sub> adenosine receptor antagonists for the development of functionalized ligands and their use in fluorescent probesStephanie Federico, Enrico Margiotta, Stefano Moro, et al.
European Journal of Medicinal Chemistry|August 26, 2018
[1,2,4]Triazolo[1,5-c]pyrimidines as adenosine receptor antagonists: Modifications at the 8 position to reach selectivity towards A<sub>3</sub> adenosine receptor subtypeStephanie Federico, Enrico Margiotta, Veronica Salmaso, et al.
Bioorganic & Medicinal Chemistry|February 13, 2014
Discovery of simplified N²-substituted pyrazolo[3,4-d]pyrimidine derivatives as novel adenosine receptor antagonists: efficient synthetic approaches, biological evaluations and molecular docking studiesGopalakrishnan Venkatesan, Priyankar Paira, Siew Lee Cheong, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
Trends in Pharmacological Sciences|November 6, 2015
Advances in Computational Techniques to Study GPCR-Ligand RecognitionAntonella Ciancetta, Davide Sabbadin, Stephanie Federico, et al.
Current Medicinal Chemistry|February 16, 2022
Glycogen Synthase Kinase 3β Involvement in Neuroinflammation and Neurodegenerative DiseasesTeresa Gianferrara, Eleonora Cescon, Ilenia Grieco, et al.
International Journal of Molecular Sciences|May 14, 2022
The Multifaceted Role of GPCRs in Amyotrophic Lateral Sclerosis: A New Therapeutic Perspective?Davide Bassani, Matteo Pavan, Stephanie Federico, et al.
Chemmedchem|October 26, 2018
Targeting Protein Kinase CK1δ with Riluzole: Could It Be One of the Possible Missing Bricks to Interpret Its Effect in the Treatment of ALS from a Molecular Point of View?Maicol Bissaro, Stephanie Federico, Veronica Salmaso, et al.
Drug Discovery Today|May 19, 2019
The current status of pharmacotherapy for the treatment of Parkinson's disease: transition from single-target to multitarget therapySiew L Cheong, Stephanie Federico, Giampiero Spalluto, et al.
RSC Medicinal Chemistry|May 28, 2021
Potent and selective A<sub>3</sub> adenosine receptor antagonists bearing aminoesters as heterobifunctional moietiesStephanie Federico, Enrico Margiotta, Stefano Moro, et al.
Current Topics in Medicinal Chemistry|May 7, 2016
Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines and Structurally Simplified Analogs. Chemistry and SAR Profile as Adenosine Receptor AntagonistsSara Redenti, Antonella Ciancetta, Giorgia Pastorin, et al.
European Journal of Medicinal Chemistry|December 3, 2019
Conjugable A<sub>3</sub> adenosine receptor antagonists for the development of functionalized ligands and their use in fluorescent probesStephanie Federico, Enrico Margiotta, Stefano Moro, et al.
European Journal of Medicinal Chemistry|August 26, 2018
[1,2,4]Triazolo[1,5-c]pyrimidines as adenosine receptor antagonists: Modifications at the 8 position to reach selectivity towards A<sub>3</sub> adenosine receptor subtypeStephanie Federico, Enrico Margiotta, Veronica Salmaso, et al.
Bioorganic & Medicinal Chemistry|February 13, 2014
Discovery of simplified N²-substituted pyrazolo[3,4-d]pyrimidine derivatives as novel adenosine receptor antagonists: efficient synthetic approaches, biological evaluations and molecular docking studiesGopalakrishnan Venkatesan, Priyankar Paira, Siew Lee Cheong, et al.
Pageof 6